Bioniz Therapeutics' Series A - II Round

Bioniz Therapeutics raised a round of funding on August 01, 2016.

Bioniz is a biopharmaceutical company leading the discovery and development of first-in-class multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, with an init…

Articles about Bioniz Therapeutics' Series A - II Round: